Publications (171) ESTELA NATIVIDAD PAZ ARTAL publications

2024

  1. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies

    HLA, Vol. 103, Núm. 6

  2. Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis(Front. Immunol., (2024), 15, (1443096), 10.3389/fimmu.2024.1443096)

    Frontiers in Immunology

  3. Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity

    Journal of Clinical Immunology, Vol. 44, Núm. 3

  4. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

    Frontiers in Immunology, Vol. 15

  5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  6. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  3. Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study

    Andrology, Vol. 11, Núm. 1, pp. 24-31

  4. Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

    Frontiers in Pediatrics, Vol. 10

  5. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  6. Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination

    Frontiers in Immunology, Vol. 14

  7. Defending against SARS-CoV-2: The T cell perspective

    Frontiers in Immunology, Vol. 14

  8. Development of an Effective Immune Response in Adults with Down Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination

    Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E155-E162

  9. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  10. Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient

    Journal of Clinical Immunology

  11. Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children

    Journal of Clinical Immunology, Vol. 43, Núm. 6, pp. 1278-1288

  12. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy

    Journal of Clinical Immunology, Vol. 43, Núm. 1, pp. 165-180

  13. Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  14. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1